Alexandra Valenti

IAM Research

The Patent 1000 focuses exclusively on patent practice and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.

Bronze - Individuals: litigation

Goodwin Procter makes light work of complex patent litigation in both the life sciences and high-technology domains, and New York is home to linchpins of both specialised practices. The firm is one of the most prolific players in Hatch-Waxman actions and an emerging leader in the field of biosimilars – see its Big Molecule Watch blog for all the latest on that front – and has a compelling trio of lawyers in Elizabeth Holland, Robert Cerwinski and Alexandra Valenti. Holland is an influential industry figure who has spent decades duking it out for pharmaceutical originators and generics. In one of her most significant ongoing cases, she is representing Novartis as complainant in an ITC action against Regeneron seeking an exclusion order against Regeneron’s newly launched Eylea pre-filled syringe product. Cerwinski is “someone you’re always happy to have on your side. He does a superb job as a team leader and gives clear strategic advice, helping clients to cut through the patent thicket”. With “outstanding IP knowledge”, he is “a sharp, creative, communicative lawyer who can be wholeheartedly recommended”. He is acting for Dr Reddy’s Laboratories in proceedings concerning its generic equivalent to Suboxone alongside Valenti and colleagues in Boston. Growing in stature and supremely confident in her trial skills, Valenti isn’t afraid of litigating outside her pharmaceutical stronghold and makes a significant contribution to the non-life sciences practice, which is headlined by Mark Abate and Calvin Wingfield. Both garner effusive client feedback: “Mark is a highly intelligent, professional and client-oriented litigation counsel. He has a deep appreciation of our patents – their development and how they improve the features and functionality of the products that embody them – along with the internal genesis of our innovations and the needs they were intended to address. He also has a deep understanding of how our products are perceived in the marketplace and therefore how to strengthen our defences. Mark collaborates well with in-house IP counsel, engineers and senior management, and is sensitive to the need for accurate litigation budget planning. All this applies equally to Calvin, who is excellent at explaining the complex aspects of patent litigation to those tasked with gathering and giving context to evidence required for presentation at trial. He meticulously tracks the evidentiary requirements to ensure they are met, and his all-round thoroughness and thoughtfulness are heartening.” They performed admirably for Pass & Seymour in a long-running dispute with Leviton Manufacturing, its core competitor in the ground-fault circuit interrupters market, emerging with a rare jury verdict of patent invalidation due to obviousness in a declaratory judgment action.

Get unlimited access to all IAM content